JPMorgan Chase
JPM
$309.87
-0.15%
JPMorgan Chase & Co. is a global financial services behemoth and one of the largest and most complex banks in the United States, operating across consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. It is a dominant market leader, distinguished by its scale, fortress balance sheet, and deep integration across the financial ecosystem. The current investor narrative is shaped by its aggressive investments in artificial intelligence, which are already yielding tangible cost savings, and a favorable regulatory environment, as recent proposals to lower capital requirements could unlock significant capital for shareholder returns and strategic initiatives.…
JPM
JPMorgan Chase
$309.87
Related headlines
Investment Opinion: Should I buy JPM Today?
Rating & Thesis: JPMorgan Chase is a Hold with a bullish bias; the stock represents a high-quality, well-capitalized banking franchise trading at a reasonable valuation, but near-term headwinds warrant patience before adding new positions. This aligns with the mixed but leaning bullish analyst consensus.
Supporting Evidence: The valuation is reasonable at a forward PE of 13.32x, a discount to its trailing multiple of 15.75x. Profitability is exceptional with a 20.39% net margin and 15.74% ROE. The company generates massive scale with $69.61 billion in quarterly revenue and unparalleled financial flexibility from $100.87 billion in TTM free cash flow. The potential regulatory catalyst for capital returns provides a tangible upside option not fully priced in.
Risks & Conditions: The two biggest risks are a further deceleration in revenue growth below 3% and continued gross margin compression. This Hold rating would upgrade to a Buy if the forward PE compresses below 12x on market weakness or if Q1 2026 results show gross margin stabilization above 59.5%. It would downgrade to Sell if revenue growth turns negative or if credit costs spike, causing a breakdown below the key technical support near $283. The stock is currently fairly valued relative to its history and growth profile.
Sign up to view all
JPM 12-Month Price Forecast
JPMorgan is a fundamentally strong company in a cautiously optimistic holding pattern. The near-term path is clouded by macro uncertainties impacting revenue and margins, justifying a neutral stance. However, its fortress balance sheet, proven execution, and unique catalysts (AI, regulation) limit downside and provide clear triggers for outperformance. The stance would upgrade to bullish on evidence of margin stabilization or a pullback to the low $290s, offering a better risk/reward entry. It would turn bearish if credit metrics deteriorate unexpectedly in the next quarterly report.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on JPMorgan Chase's 12-month outlook, with a consensus price target around $402.83 and implied upside of +30.0% versus the current price.
Average Target
$402.83
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$248 - $403
Analyst target range
Analyst coverage for this mega-cap bank is extensive, though the provided data sample shows only 5 analysts with an average EPS estimate of $25.66 for the coming period. The institutional ratings reveal a consistently bullish bias, with recent actions from firms like Piper Sandler, Wells Fargo, and Barclays maintaining 'Overweight' or 'Outperform' ratings, while others like Truist Securities and Morgan Stanley have 'Hold' or 'Equal Weight' stances. The consensus leans bullish, but the presence of neutral ratings indicates some caution regarding the pace of earnings growth or macroeconomic headwinds. The target price range, implied by the EPS estimates, spans from a low of $24.84 to a high of $27.61, reflecting differing assumptions on net interest income trajectories, credit costs, and capital return capabilities. The tight clustering of revenue estimates (average $214.24 billion, range ~$4 billion) suggests high conviction on the top-line outlook, while the wider EPS range points to greater uncertainty around operating leverage and provision expenses.
Bulls vs Bears: JPM Investment Factors
The evidence currently tilts slightly bullish, supported by JPMorgan's unparalleled financial strength, tangible AI benefits, and a favorable regulatory backdrop. However, the bear case presents credible near-term risks from decelerating revenue growth and margin pressure. The single most important tension in the investment debate is the trajectory of net interest income and operating margins: will AI-driven cost savings and potential regulatory tailwinds outweigh the pressures from a potentially less favorable rate environment and slowing loan growth? The resolution of this margin dynamic will likely determine whether the stock re-rates higher or remains range-bound.
Bullish
- Fortress Balance Sheet & Massive FCF: JPMorgan generates immense free cash flow, with $100.87 billion on a TTM basis, providing unparalleled financial flexibility for shareholder returns and strategic investments. This cash generation underpins its fortress balance sheet, a key differentiator in the banking sector.
- AI Investment Driving Tangible Cost Savings: The company's $2 billion annual AI investment is already achieving a 1-to-1 return through direct cost savings, providing a clear efficiency lead over peers. This positions JPM to defend and potentially expand its robust 20.39% net margin in a competitive environment.
- Favorable Regulatory Catalyst for Capital Returns: Recent proposals to lower capital requirements for large banks could unlock tens of billions in capital for JPMorgan. This potential regulatory windfall would directly support increased dividends, share buybacks, and strategic lending initiatives.
- Attractive Valuation Relative to History: Trading at a trailing PE of 15.75x, the stock is below its own historical average (e.g., 17.25x at end of Q4 2025). The forward PE of 13.32x implies a discount for continued earnings growth, offering relative value for a market leader.
Bearish
- Revenue Growth Deceleration: Q4 2025 revenue grew only 3.88% YoY, a significant slowdown from stronger prior quarters. This deceleration raises concerns about the bank's ability to maintain top-line momentum, particularly if net interest income faces further pressure.
- Gross Margin Compression: Gross margin compressed to 59.11% in Q4 2025 from 60.11% in Q2 2025, reflecting pressure from the interest rate environment on net interest income. This sequential decline suggests potential headwinds to core banking profitability.
- Technical Downtrend & Volatility: The stock is in a volatile downtrend over the last three months, down -5.87%, despite a strong 1-year performance. Trading near 92% of its 52-week range but having retreated from highs indicates a loss of momentum and potential for further correction.
- Elevated Debt & Macro Sensitivity: With a debt-to-equity ratio of 2.60 and a beta of 1.043, JPM is leveraged and exhibits market-like volatility. This makes it sensitive to macroeconomic shifts, particularly regarding interest rates and credit conditions, which could pressure earnings.
JPM Technical Analysis
The stock is in a period of range-bound consolidation with a volatile downtrend over the last six months, evidenced by a 1-year price change of +36.44% but a 3-month decline of -5.87%. Currently trading at $309.87, the price sits at approximately 92% of its 52-week range ($225.00 to $337.25), indicating it is near the upper end of its recent band but has retreated from the highs, suggesting a loss of momentum after a strong prior run. Recent momentum shows a sharp short-term recovery, with the stock up 7.77% over the past month, significantly outperforming the SPY's 0.46% gain, yet this positive move conflicts with the negative 3-month trend, signaling a potential rebound within a broader corrective phase rather than a confirmed trend reversal. Key technical support is anchored at the 52-week low of $225.00, while immediate resistance is at the 52-week high of $337.25; a decisive breakout above resistance would signal a resumption of the primary uptrend, while a breakdown below the recent March lows near $283 could indicate a deeper correction. With a beta of 1.043, the stock exhibits market-like volatility, but its recent 1-month relative strength of +7.31% highlights its recent outperformance amid broader market uncertainty.
Beta
1.04
1.04x market volatility
Max Drawdown
-16.3%
Largest decline past year
52-Week Range
$226-$337
Price range past year
Annual Return
+36.4%
Cumulative gain past year
| Period | JPM Return | S&P 500 |
|---|---|---|
| 1m | +7.8% | +2.6% |
| 3m | -5.9% | -2.3% |
| 6m | +3.0% | +2.6% |
| 1y | +36.4% | +27.3% |
| ytd | -4.8% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JPM Fundamental Analysis
Revenue growth has been steady but decelerating, with Q4 2025 revenue of $69.61 billion representing a 3.88% year-over-year increase, a slowdown from the stronger growth seen in prior quarters of 2025. The revenue mix is balanced, with the Consumer & Community Banking segment contributing $19.40 billion and the Commercial & Investment Bank adding $19.38 billion in the latest period, indicating diversified drivers. The company is highly profitable, reporting Q4 2025 net income of $13.03 billion and a robust net margin of 20.39%, though gross margin compressed sequentially to 59.11% from 60.11% in Q2 2025, reflecting the interest rate environment's pressure on net interest income. Profitability remains strong with a Return on Equity (ROE) of 15.74%, showcasing efficient capital utilization. The balance sheet is a source of strength, with substantial free cash flow generation of $100.87 billion on a TTM basis, providing ample internal funding for dividends, buybacks, and investments. The debt-to-equity ratio of 2.60 is elevated but typical for a leveraged financial institution, and the current ratio of 0.52 indicates a liquidity profile focused on the banking business model rather than traditional corporate metrics.
Quarterly Revenue
$69.6B
2025-12
Revenue YoY Growth
+0.03%
YoY Comparison
Gross Margin
+0.59%
Latest Quarter
Free Cash Flow
$100.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JPM Overvalued?
Given its substantial net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 15.75x and a forward PE of 13.32x, with the forward discount implying market expectations for continued, albeit potentially slower, earnings growth. Compared to sector averages, JPM's valuation presents a mixed picture; its trailing PE of 15.75x is below the typical premium for a market leader, while its Price-to-Sales (PS) ratio of 3.21x and Price-to-Book (PB) ratio of 2.48x need context against banking peers, which often trade closer to book value. The current trailing PE of 15.75x sits below its own historical average observed in the provided data (e.g., 17.25x at the end of Q4 2025), suggesting the stock is not at extended historical valuation highs and may offer relative value if earnings stabilize or re-accelerate.
PE
15.8x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 7x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: JPMorgan faces margin pressure, with gross margin compressing 100 basis points sequentially to 59.11% in Q4 2025, indicating sensitivity to interest rate fluctuations. While the debt-to-equity ratio of 2.60 is typical for a leveraged bank, it amplifies earnings volatility. Revenue growth deceleration to 3.88% YoY poses a risk if the bank cannot offset slowing top-line expansion with continued cost discipline, especially as it invests heavily in AI and technology.
Market & Competitive Risks: The stock's valuation, while below its historical average, carries compression risk if earnings growth fails to meet expectations implied by its forward PE of 13.32x. Its beta of 1.043 means it is highly correlated to broader market movements, exposing it to sector rotations and macroeconomic downturns. Recent news highlights stagflationary headwinds from geopolitical conflicts, which could delay Fed rate cuts and further pressure net interest margins, a key profit driver.
Worst-Case Scenario: A severe economic downturn coupled with a hawkish Fed maintaining high rates could trigger a dual shock of rising credit losses and collapsing net interest margins. This scenario could drive earnings significantly below estimates, leading to multiple compression. The realistic downside could see the stock retesting its 52-week low of $225, representing a potential loss of approximately -27% from the current price of $309.87, exacerbated by its recent maximum drawdown of -16.27% demonstrating vulnerability to sharp corrections.
FAQ
The key risks are, in order of severity: 1) Macroeconomic & Interest Rate Risk: The stock's beta of 1.043 and gross margin compression show sensitivity to rate shifts and economic cycles, with stagflation being a worst-case scenario. 2) Credit Risk: An economic downturn could spike loan loss provisions, impacting the strong 20.39% net margin. 3) Operational Risk: Revenue growth has decelerated to 3.88% YoY; a further slowdown could pressure the valuation multiple. 4) Regulatory Risk: The anticipated capital relief could be delayed or diluted, removing a key catalyst for shareholder returns.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $315 and $337, driven by stable execution, consistent buybacks, and meeting the average analyst EPS estimate of $25.66. The Bull Case (30% probability) targets $337 to $365, requiring successful regulatory capital relief and AI-driven margin expansion. The Bear Case (15% probability) warns of a drop to $225-$290 if a recession triggers credit losses and margin pressure. The Base Case is most likely, assuming the current macro uncertainty persists without a sharp downturn.
JPM stock is fairly valued relative to its own history and growth prospects. It trades at a trailing PE of 15.75x, which is below its recent historical average (e.g., 17.25x), suggesting it is not extended. The forward PE of 13.32x implies the market expects modest earnings growth, which aligns with its recent 3.88% revenue growth rate. Compared to banking peers, its Price-to-Book ratio of 2.48x commands a premium justified by its superior ROE of 15.74%. The valuation implies the market is pricing in stable execution but not significant acceleration.
JPM is a good buy for patient, long-term investors seeking a high-quality banking franchise at a fair price, but not an urgent buy for short-term traders. The stock offers a reasonable forward PE of 13.32x, a solid dividend yield near 1.85%, and significant upside optionality from AI savings and regulatory changes. However, near-term headwinds from revenue deceleration and margin pressure suggest waiting for a better entry point below $300 or for clearer signs of fundamental stabilization in the next earnings report. The biggest downside risk is a deterioration in credit quality amid a slowing economy.
JPM is unequivocally suitable for long-term investment with a minimum holding period of 3-5 years. Its value proposition is built on compounding dividends, share repurchases, and the durable competitive advantages of scale—themes that play out over years, not quarters. While its beta of 1.043 allows for some trading around core positions, short-term trading is challenged by macroeconomic volatility impacting bank stocks. Long-term investors can weather near-term margin pressure to capture the benefits of AI efficiency, regulatory changes, and the bank's cyclical recovery when the economic picture improves.